Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thirty two cases of acute
Wernicke's encephalopathy
were observed in a period of 33 months, and prior to the mandatory thiamine enrichment of Australian bread-making flour in 1991. These cases were carefully assessed by multiple tests at specified intervals prior to, and following thiamine administration until discharge from hospital. Structured scoring of neurological signs and symptoms, CT scans, psychometry, nutritional measurements, and liver biopsies were performed. There was variation in the presentation and severity of clinical signs and symptoms and in response to treatment. All patients had alcohol-related liver disease, and the results indicated that
fatty liver
was important in presentation and in response to treatment with thiamine. Other forms of alcohol related brain damage were present in these patients, most of whom were in the 4th or 5th decade of life and had been drinking beer to excess for more than 20 years.
...
PMID:Presentation of acute Wernicke's encephalopathy and treatment with thiamine. 759 29
Objective:
The development of these updated clinical practice guidelines (CPGs) was commissioned by the American Association of Clinical Endocrinologists (AACE), The Obesity Society, American Society of Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists Boards of Directors in adherence with the AACE 2017 protocol for standardized production of CPGs, algorithms, and checklists.
Methods:
Each recommendation was evaluated and updated based on new evidence from 2013 to the present and subjective factors provided by experts.
Results:
New or updated topics in this CPG include: contextualization in an adiposity-based chronic disease complications-centric model, nuance-based and algorithm/checklist-assisted clinical decision-making about procedure selection, novel bariatric procedures, enhanced recovery after bariatric surgery protocols, and logistical concerns (including cost factors) in the current health-care arena. There are 85 numbered recommendations that have updated supporting evidence, of which 61 are revised and 12 are new. Noting that there can be multiple recommendation statements within a single numbered recommendation, there are 31 (13%) Grade A, 42 (17%) Grade B, 72 (29%) Grade C, and 101 (41%) Grade D recommendations. There are 858 citations, of which 81 (9.4%) are evidence level (EL) 1 (highest), 562 (65.5%) are EL 2, 72 (8.4%) are EL 3, and 143 (16.7%) are EL 4 (lowest).
Conclusion:
Bariatric procedures remain a safe and effective intervention for higher-risk patients with obesity. Clinical decision-making should be evidence based within the context of a chronic disease. A team approach to perioperative care is mandatory, with special attention to nutritional and metabolic issues.
A1C
= hemoglobin A1c;
AACE
= American Association of Clinical Endocrinologists;
ABCD
= adiposity-based chronic disease;
ACE
= American College of Endocrinology;
ADA
= American Diabetes Association;
AHI
= Apnea-Hypopnea Index;
ASA
= American Society of Anesthesiologists;
ASMBS
= American Society of Metabolic and Bariatric Surgery;
BMI
= body mass index;
BPD
= biliopancreatic diversion;
BPD/DS
= biliopancreatic diversion with duodenal switch;
CI
= confidence interval;
CPAP
= continuous positive airway pressure;
CPG
= clinical practice guideline;
CRP
= C-reactive protein;
CT
= computed tomography;
CVD
= cardiovascular disease;
DBCD
= dysglycemia-based chronic disease;
DS
= duodenal switch;
DVT
= deep venous thrombosis;
DXA
= dual-energy X-ray absorptiometry;
EFA
= essential fatty acid;
EL
= evidence level;
EN
= enteral nutrition;
ERABS
= enhanced recovery after bariatric surgery;
FDA
= U.S. Food and Drug Administration;
G4G
= Guidelines for Guidelines;
GERD
= gastroesophageal reflux disease;
GI
= gastrointestinal;
HCP
= health-care professional(s);
HTN
= hypertension;
ICU
= intensive care unit;
IGB
= intragastric balloon(s);
IV
= intravenous;
LAGB
= laparoscopic adjustable gastric band;
LAGBP
= laparoscopic adjustable gastric banded plication;
LGP
= laparoscopic greater curvature (gastric) plication;
LRYGB
= laparoscopic Roux-en-Y gastric bypass;
LSG
= laparoscopic sleeve gastrectomy;
MetS
= metabolic syndrome;
NAFLD
= nonalcoholic
fatty liver
disease;
NASH
= nonalcoholic steatohepatitis;
NSAID
= nonsteroidal anti-inflammatory drug;
OA
= osteoarthritis;
OAGB
= one-anastomosis gastric bypass;
OMA
= Obesity Medicine Association;
OR
= odds ratio;
ORC
= obesity-related complication(s);
OSA
= obstructive sleep apnea;
PE
= pulmonary embolism;
PN
= parenteral nutrition;
PRM
= pulmonary recruitment maneuver;
RCT
= randomized controlled trial;
RD
= registered dietician;
RDA
= recommended daily allowance;
RYGB
= Roux-en-Y gastric bypass;
SG
= sleeve gastrectomy;
SIBO
= small intestinal bacterial overgrowth;
TOS
= The Obesity Society;
TSH
= thyroid-stimulating hormone;
T1D
= type 1 diabetes;
T2D
= type 2 diabetes;
VTE
= venous thromboembolism;
WE
=
Wernicke encephalopathy
;
WHO
= World Health Organization.
...
PMID:CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS -
EXECUTIVE SUMMARY
. 3168 18